Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-13

FDA Approved: LACOSAMIDE — Original Application (Apotex Corp)

View source ↗

Summary

FDA approved Apotex Corp's original ANDA for lacosamide, authorizing a generic version of the anticonvulsant used to treat partial-onset seizures in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)